| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.4 |